CME Group Inc. $CME Stock Sold by Mawer Investment Management Ltd.

Mawer Investment Management Ltd. trimmed its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 16.1% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 801,639 shares of the financial services provider’s stock after selling 154,303 shares during the period. CME Group comprises about 1.5% of Mawer Investment Management Ltd.’s portfolio, making the stock its 23rd largest holding. Mawer Investment Management Ltd.’s holdings in CME Group were worth $210,013,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of CME. First Community Trust NA purchased a new position in CME Group in the 3rd quarter worth about $26,000. North Point Portfolio Managers Corp OH purchased a new stake in shares of CME Group during the 3rd quarter valued at about $26,000. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in shares of CME Group during the 2nd quarter valued at about $28,000. Compass Financial Management LLC boosted its holdings in shares of CME Group by 471.4% during the 3rd quarter. Compass Financial Management LLC now owns 120 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 99 shares during the last quarter. Finally, Main Street Group LTD bought a new stake in shares of CME Group in the first quarter worth approximately $32,000. 87.75% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Daniel Kaye sold 532 shares of the company’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $304.17, for a total transaction of $161,818.44. Following the completion of the sale, the director owned 4,313 shares of the company’s stock, valued at $1,311,885.21. This represents a 10.98% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 5,000 shares of the stock in a transaction that occurred on Tuesday, October 27th. The stock was sold at an average price of $298.70, for a total transaction of $1,493,500.00. Following the completion of the transaction, the insider owned 20,037 shares in the company, valued at $5,985,051.90. This trade represents a 19.97% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 33,511 shares of company stock worth $9,714,580. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

CME has been the subject of several research reports. Wells Fargo & Company boosted their price objective on shares of CME Group from $315.00 to $333.00 and gave the company an “overweight” rating in a report on Thursday, October 22nd. Bank of America increased their price objective on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research report on Thursday, July 23rd. TD Cowen raised their target price on shares of CME Group from $292.00 to $300.00 and gave the stock a “buy” rating in a report on Monday, October 5th. Morgan Stanley raised their target price on shares of CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Finally, Weiss Ratings raised shares of CME Group from a “buy (b-)” rating to a “buy (b)” rating in a research report on Friday, October 23rd. Ten equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $314.44.

Read Our Latest Stock Analysis on CME Group

CME Group Stock Performance

CME Group stock traded up $2.47 during mid-day trading on Friday, reaching $317.97. 1,579,861 shares of the stock traded hands, compared to its average volume of 2,061,318. The stock has a market capitalization of $113.81 billion, a PE ratio of 26.08, a price-to-earnings-growth ratio of 3.85 and a beta of 0.15. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The business’s 50-day moving average is $286.01 and its 200-day moving average is $281.54.

CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, beating analysts’ consensus estimates of $2.99 by $0.03. The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. CME Group’s revenue was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.68 earnings per share. As a group, sell-side analysts predict that CME Group Inc. will post 12.35 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Friday, December 11th. This represents a $5.20 annualized dividend and a dividend yield of 1.6%. CME Group’s dividend payout ratio is presently 42.66%.

CME Group Company Profile

(Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.